Company / Net Income
Minerva Neurosciences, Inc. Net Income History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$1.4M
FY2024
5-year range
-$72.2M / $1.9M
FY2020-FY2024
Trend
+104.5%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has fluctuated over the past 8 years, ranging from -$72M in FY2020 to $2M in FY2021.
Based on SEC 10-K filings.
$1M in FY2024 with a 3-year CAGR of -9.5%.
Improved from -$50M to $1M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -9.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -9.5%, indicating a declining trend.
- In FY2024, net income increased 104.5% year-over-year.
- Peak net income was recorded in FY2021.
- Lowest net income in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -10.64 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.4M | +104.5% |
| FY2023 | -$32.1M | +35.7% |
| FY2022 | -$49.9M | -2671.4% |
| FY2021 | $1.9M | +102.7% |
| FY2020 | -$72.2M | -43.9% |
| FY2019 | -$50.2M | -59.2% |
| FY2018 | -$31.5M | -16.4% |
| FY2017 | -$27.1M | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026